Alexion Pharmaceuticals, Inc.
NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021
ALXN Articles
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
Published:
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Portola Pharmaceuticals shares more than doubled on Tuesday after the company announced that it would be acquired by Alexion Pharmaceuticals.
Published:
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
Published:
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Published:
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
Published:
Monday's top analyst upgrades, downgrades and initiations included Alexion, American Water Works, Apple, Schwab, Crowdstrike, FedEx, IBM, Microsoft, Nvidia, Ryanair and Tesla.
Published:
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Published:
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published: